Related Experiment Video
Updated: Jul 10, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data
Manuela Harries1, Veronika K Jaeger2, Isti Rodiah3
1Department of Epidemiology, Helmholtz Centre for Infection Research Braunschweig, Germany; Institute for Epidemiology Social Medicine and Health Systems Research, Hannover Medical School (MHH) Hannover, Germany.
Objectives:
Throughout the SARS-CoV-2 pandemic, Germany like other countries lacked adaptive population-based panels to monitor the spread of epidemic diseases.
Methods:
To fill a gap in population-based estimates needed for winter 2022/23 we resampled in the German SARS-CoV-2 cohort study MuSPAD in mid-2022, including characterization of systemic cellular and humoral immune responses by interferon-γ-release assay (IGRA) and CLIA/IVN assay. We were able to confirm categorization of our study population into four groups with differing protection levels against severe COVID-19 courses based on literature synthesis. Using these estimates, we assessed potential healthcare burden for winter 2022/23 in different scenarios with varying assumptions on transmissibility, pathogenicity, new variants, and vaccine booster campaigns in ordinary differential equation models.
Results:
We included 9921 participants from eight German regions. While 85% of individuals were located in one of the two highest protection categories, hospitalization estimates from scenario modeling were highly dependent on viral variant characteristics ranging from 30-300% compared to the 02/2021 peak. Our results were openly communicated and published to an epidemic panel network and a newly established modeling network.
Conclusions:
We demonstrate feasibility of a rapid epidemic panel to provide complex immune protection levels for inclusion in dynamic disease burden modeling scenarios.
More Related Videos
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Steps in Outbreak Investigation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Bias in Epidemiological Studies

